Cargando…
A dual inhibitor of the proteasome catalytic subunits LMP2 and Y attenuates disease progression in mouse models of Alzheimer’s disease
The immunoproteasome (iP) is a variant of the constitutive proteasome (cP) that is abundantly expressed in immune cells which can also be induced in somatic cells by cytokines such as TNF-α or IFN-γ. Accumulating evidence support that the iP is closely linked to multiple facets of inflammatory respo...
Autores principales: | Yeo, In Jun, Lee, Min Jae, Baek, Ahruem, Miller, Zachary, Bhattarai, Deepak, Baek, Yu Mi, Jeong, Hyun Jung, Kim, Yun Kyung, Kim, Dong-Eun, Hong, Jin Tae, Kim, Kyung Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895163/ https://www.ncbi.nlm.nih.gov/pubmed/31804556 http://dx.doi.org/10.1038/s41598-019-54846-z |
Ejemplares similares
-
Oxidative stress causes Alu RNA accumulation via PIWIL4 sequestration into stress granules
por: Hwang, Yeo Eun, et al.
Publicado: (2019) -
Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcma
por: Hayashi, Takuma, et al.
Publicado: (2011) -
Expression of catalytic proteasome subunits in the gut of patients with Crohn’s disease
por: Visekruna, Alexander, et al.
Publicado: (2009) -
H727 cells are inherently resistant to the proteasome inhibitor carfilzomib, yet require proteasome activity for cell survival and growth
por: Lee, Min Jae, et al.
Publicado: (2019) -
Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia
por: Du, Sheng-hong, et al.
Publicado: (2021)